ArticleUpdates in surgery2026
Necessity of systematic lymph node dissection in early-stage pure solid lung cancer adjacent to the mediastinum.
Article in Updates in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Construction and validation of a predictive model for benefits of tunnel-type mediastinal lymph node dissection in lung cancer patients based on the SEER database.BMC medical informatics and decision making · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Pure solid lung cancer is associated with higher lymph node metastasis rates, therefore identifying the risk factors and metastatic patterns of lymph node involvement in early-stage pure solid lung cancer is a critical research topic. We retrospectively collected preoperative Computed Tomography (CT) imaging and postoperative pathological data of patients with pure solid lung cancer from 2021 to 2025 to investigate the risk factors and patterns of lymph node metastasis. Among 8718 patients, 104 with ≤ 2 cm pure solid lung cancer were analyzed, with a lymph node metastasis rate of 20.19% (21/104). Risk factors included mediastinal proximity (Odds Ratio (OR) = 11.83, 95% CI 2.18-64.32, p = 0.004) and ALK-positivity (OR = 15.13, 95% CI 1.68-136.01, p = 0.015). In 76 clinical stage IA patients, the metastasis rate was 15.79% (12/76). Risk factors were mediastinal proximity (OR = 11.53, 95% CI 1.13-118.01, p = 0.039), and ALK-positivity (OR = 33.74, 95% CI 3.02-376.65, p = 0.004). Upper lobe pure solid lung cancers tended to metastasize to the superior mediastinal lymph nodes (p = 0.011). Mediastinal proximity and ALK-positivity were independent risk factor of lymph node metastasis in pure solid lung cancer. Systematic lymph node dissection is proper for mediastinal-adjacent pure solid lung cancer.
Indexed as
Identifiers
40886253What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.